Welcome to our dedicated page for WW International news (Ticker: WW), a resource for investors and traders seeking the latest updates and insights on WW International stock.
WW International, Inc. (WeightWatchers), trading under the symbol WW, is frequently in the news for developments in science-backed weight management, clinical programs, and digital health innovation. Company announcements emphasize its role as a global leader in weight health, combining behavioral programs, clinical care, GLP‑1 medications when appropriate, and technology-enabled support.
News about WeightWatchers often covers updates to its integrated GLP‑1 platform, including the WeightWatchers Med+ program and the GLP‑1 Success behavioral support experience. Releases have highlighted access to FDA‑approved GLP‑1 treatments, such as an oral formulation of Wegovy, and the company’s positioning as a NovoCare Recognized Care Provider. These stories focus on how WeightWatchers pairs medication access with evidence‑based nutrition, coaching, and community to improve outcomes.
Investors and observers will also find coverage of new product and feature launches within the WeightWatchers app, such as the Weight Health Score, AI Body Scanner, fitness content partnerships, and configurable Modes that adjust support as members move from weight loss to maintenance. Additional news items include the launch of specialized programs like WeightWatchers for Menopause, the publication of WeightWatchers for Business annual results, collaborations with partners like Amazon Pharmacy, and the introduction of the WeightWatchers Awards for health and wellness products.
On this news page, readers can track earnings announcements, conference participation, leadership appointments, and strategic initiatives related to WeightWatchers’ transformation in the GLP‑1 era. For those following WW stock or the broader weight health sector, the news feed provides a centralized view of how the company is evolving its behavioral and clinical businesses, expanding partnerships, and refining its global weight management platform.
WW International has announced its acquisition of Weekend Health, operating as Sequence, for $132 million in a cash and equity deal. This strategic move aims to integrate Sequence's telehealth platform, which focuses on chronic weight management, with WeightWatchers’ nutrition and behavior-change programs. Sequence has generated an annual revenue run-rate of approximately $25 million and serves around 24,000 members. The deal is set to close in Q2 2023, contingent on customary conditions. The acquisition is expected to enhance the company’s offerings in the weight management sector, leveraging both technology and clinical support.
WW International, known as WeightWatchers, announces its participation at the Morgan Stanley Technology, Media and Telecom Conference on March 8, 2023, at 11:00 am ET. CEO Sima Sistani will deliver the presentation. Investors can access the live audio webcast on the corporate website under the Investors section, with an archive available for 30 days. WeightWatchers focuses on helping individuals adopt healthy habits through its comprehensive weight management program, leveraging technology, tools, and expert coaching developed over nearly six decades.
WW International, Inc. (NASDAQ: WW) has announced it will release its 2022 fourth quarter and full year results after the market closes on March 6, 2023. A conference call is scheduled for 5:00 p.m. ET that same day, where CEO Sima Sistani and Interim Principal Financial Officer Heather Stark will discuss the results and address questions from investors. A live webcast of the call will be available on the company's corporate website, alongside supplemental investor materials. The webcast replay will remain accessible for approximately 90 days.
WW is recognized for its human-centric technology and leading weight management program, promoting healthy habits for nearly six decades.
WW International announced significant leadership changes, including the departure of Amy O'Keefe as Chief Financial Officer, effective December 2, 2022. Heather Stark will serve as interim Principal Financial Officer. Tiffany Stevenson has been appointed Chief People Officer, effective January 2023, while David Cohen has been named Chief Data Officer. CEO Sima Sistani expressed gratitude for O'Keefe's leadership and emphasized the appointment of Stevenson and Cohen as pivotal for the company's goal of becoming more tech-centric and optimizing for profitable growth.
WW International, Inc. (NASDAQ: WW) reported Q3 2022 results with revenues at $249.7 million, reflecting a 14.9% decline year-over-year. The company recorded an operating loss of $254.5 million, influenced by $312.7 million in non-cash intangible impairment charges. Q3 adjusted operating income was $61.9 million, down 30.0% year-over-year. The end of period subscribers decreased by 15.0% to 3.8 million. For FY 2022, revenue guidance has been revised to approximately $1.04 billion, and GAAP diluted net loss per share is expected between ($3.16) and ($3.21).
WW International, Inc. (NASDAQ: WW) will announce its third-quarter 2022 results on November 3, 2022, after market close. A conference call will follow at 5:00 p.m. ET, featuring CEO Sima Sistani and CFO Amy O’Keefe discussing the results and answering investor questions. The call can be accessed via the company's website, with supplemental materials available beforehand. The company emphasizes its commitment to supporting members in achieving healthy habits through its weight management program, leveraging nearly six decades of experience.
WW International reported Q2 2022 revenues of $269.5 million, down 13.5% year-over-year. The company had 4.3 million end-of-period subscribers, a 12.3% decline compared to the previous year. Operating income fell to $13.4 million, a 77.6% drop from Q2 2021. The company recorded non-cash impairment charges of $26.4 million and revised its full-year guidance to revenues between $1.05 billion and $1.09 billion. Despite these challenges, adjusted operating income was $58.3 million, reflecting cost management efforts.
WW International (NASDAQ: WW) will announce its Q2 2022 results on August 4, 2022, after market close. A conference call, featuring CEO Sima Sistani and CFO Amy O’Keefe, is scheduled for 5:00 p.m. ET to discuss the results and address investor questions. Interested parties can access a live webcast on the company's corporate website, where supplemental materials will also be available. The event will be archived for 90 days. WW has focused on providing a science-based weight management program backed by technology and community support.
WW International, Inc. (NASDAQ: WW) announced positive results from a clinical trial presented at the ADA 82nd Scientific Sessions. The trial evaluated its diabetes-specific program for weight management, involving 136 participants with Type 2 diabetes. Key findings include a reduction in HbA1c levels by 0.76, an average weight loss of 5.7%, and decreased diabetes distress by 9.8%. These improvements exceed FDA standards, indicating the program's effectiveness in promoting health among those living with diabetes. The study highlights the relevance of weight management in managing diabetes.
WW International reported Q1 2022 results with revenues of $297.8 million, a 10.3% decline from Q1 2021. The company experienced an 8.3% decrease in subscribers, totaling 4.5 million. Despite revenue declines, Q1 operating income rose to $9.0 million, significantly up from $2.8 million in the previous year, aided by cost management and reduced marketing expenses. The 2022 restructuring plan is projected to save nearly $30 million annually. FY 2022 guidance anticipates revenues of $1.09 billion to $1.14 billion and GAAP EPS between $0.72 and $0.78.
FAQ
What is the current stock price of WW International (WW)?
What is the market cap of WW International (WW)?
